Greenyn Biotechnology Co., Ltd (TPEX:6846)

Market Cap	1.58B -23.8%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	26.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	3.94 (6.59%)
Ex-Dividend Date	Jun 25, 2026

Volume	4,011
Open	57.40
Previous Close	59.90
Day's Range	57.40 - 58.70
52-Week Range	55.60 - 78.20
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Greenyn Biotechnology

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 159
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6846

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error